Jenkins RB - Search Results

1

A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma.

Halling KC, King W, Sokolova IA, Meyer RG, Burkhardt HM, Halling AC, Cheville JC, Sebo TJ, Ramakumar S, Stewart CS, Pankratz S, O'Kane DJ, Seelig SA, Lieber MM, Jenkins RB. Halling KC, et al. Among authors: jenkins rb. J Urol. 2000 Nov;164(5):1768-75. J Urol. 2000. PMID: 11025767

2

Fluorescence in situ hybridization: a sensitive method for trisomy 8 detection in bone marrow specimens.

Jenkins RB, Le Beau MM, Kraker WJ, Borell TJ, Stalboerger PG, Davis EM, Penland L, Fernald A, Espinosa R 3rd, Schaid DJ, et al. Jenkins RB, et al. Blood. 1992 Jun 15;79(12):3307-15. Blood. 1992. PMID: 1596571 Free article.

3

Chromosomal anomalies in atypical adenomatous hyperplasia and carcinoma of the prostate using fluorescence in situ hybridization.

Qian J, Jenkins RB, Bostwick DG. Qian J, et al. Among authors: jenkins rb. Urology. 1995 Dec;46(6):837-42. doi: 10.1016/S0090-4295(99)80354-9. Urology. 1995. PMID: 7502426

4

Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer.

Alcaraz A, Takahashi S, Brown JA, Herath JF, Bergstralh EJ, Larson-Keller JJ, Lieber MM, Jenkins RB. Alcaraz A, et al. Among authors: jenkins rb. Cancer Res. 1994 Aug 1;54(15):3998-4002. Cancer Res. 1994. PMID: 7518348

5

Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer.

Cher ML, MacGrogan D, Bookstein R, Brown JA, Jenkins RB, Jensen RH. Cher ML, et al. Among authors: jenkins rb. Genes Chromosomes Cancer. 1994 Nov;11(3):153-62. doi: 10.1002/gcc.2870110304. Genes Chromosomes Cancer. 1994. PMID: 7530484

6

Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization.

Qian J, Bostwick DG, Takahashi S, Borell TJ, Herath JF, Lieber MM, Jenkins RB. Qian J, et al. Among authors: jenkins rb. Cancer Res. 1995 Nov 15;55(22):5408-14. Cancer Res. 1995. PMID: 7585610

7

Use of fluorescence in situ hybridization to detect loss of chromosome 10 in astrocytomas.

Dalrymple SJ, Herath JF, Ritland SR, Moertel CA, Jenkins RB. Dalrymple SJ, et al. Among authors: jenkins rb. J Neurosurg. 1995 Aug;83(2):316-23. doi: 10.3171/jns.1995.83.2.0316. J Neurosurg. 1995. PMID: 7616278

8

Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression.

Takahashi S, Shan AL, Ritland SR, Delacey KA, Bostwick DG, Lieber MM, Thibodeau SN, Jenkins RB. Takahashi S, et al. Among authors: jenkins rb. Cancer Res. 1995 Sep 15;55(18):4114-9. Cancer Res. 1995. PMID: 7664288

9

Fluorescence in situ hybridization analysis of trisomy 12 in ovarian tumors.

Persons DL, Hartmann LC, Herath JF, Keeney GL, Jenkins RB. Persons DL, et al. Among authors: jenkins rb. Am J Clin Pathol. 1994 Dec;102(6):775-9. doi: 10.1093/ajcp/102.6.775. Am J Clin Pathol. 1994. PMID: 7801890

10

Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies.

Takahashi S, Qian J, Brown JA, Alcaraz A, Bostwick DG, Lieber MM, Jenkins RB. Takahashi S, et al. Among authors: jenkins rb. Cancer Res. 1994 Jul 1;54(13):3574-9. Cancer Res. 1994. PMID: 8012984

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

460 results

Search Page

Filters